Clinical trial
An Open Label Study of STR04 in Participants With Amyotrophic Lateral Sclerosis
NCT06910384 is registered in ClinicalTrials.gov with New England Cell Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Label Study of STR04 in Participants With Amyotrophic Lateral Sclerosis
- Lead sponsor
- New England Cell Therapeutics, Inc.
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- August 12, 2025
- Completion date
- December 16, 2025
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.